KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Current Deferred Revenue (2016 - 2026)

National Health Investors filings provide 18 years of Current Deferred Revenue readings, the most recent being $5.2 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue rose 26.94% to $5.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.2 million, a 26.94% increase, with the full-year FY2025 number at $5.0 million, up 16.81% from a year prior.
  • Current Deferred Revenue hit $5.2 million in Q1 2026 for National Health Investors, up from $5.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $6.0 million in Q4 2023 to a low of $4.0 million in Q3 2025.
  • Median Current Deferred Revenue over the past 5 years was $5.0 million (2025), compared with a mean of $4.8 million.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 60.95% in 2022 and later rose 26.94% in 2026.
  • National Health Investors' Current Deferred Revenue stood at $5.1 million in 2022, then increased by 18.94% to $6.0 million in 2023, then decreased by 28.82% to $4.3 million in 2024, then rose by 16.81% to $5.0 million in 2025, then grew by 4.22% to $5.2 million in 2026.
  • The last three reported values for Current Deferred Revenue were $5.2 million (Q1 2026), $5.0 million (Q4 2025), and $4.0 million (Q3 2025) per Business Quant data.